Dusmani, Arsani H.
HRN: 26-48-28 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/09/2025
MUPIROCIN 2%, 15G (TUBE)
02/09/2025
02/16/2025
TOPICAL
2%
BID
Scabies
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes